About Alector (ALEC)
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
- USD1.47
- USD1.53
- USD1.33
- USD6.14
- -52.50%
- 81M
- 6.64M
- 3.23M
- 308M
- 0.87
- -67.40%
Stock News
5 hours ago
NICE: Though Balanced Risk/Reward, Wait For Accelerated Growth
SeekingAlpha
yesterday
Invest in stocks and avoid 1990s-like speculation that seems so tempting
CNBC
yesterday
U.S., China say trade-deal groundwork has been laid ahead of Trump-Xi meeting
MarketWatch
yesterday
Ice Cold, Zen-Like Investing With Alex King
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
